卡培他滨和氟尿嘧啶的毒副作用相似。
Toxic effects of capecitabine and fluorouracil were similar.
目的探讨吉西他滨在乳腺癌化疗中的作用。
Objective To study the antitumor effect of gemcitabine in chemotherapy with breast cancer.
吉西他滨目前是作为胰腺癌术后的标准治疗药物。
Gemzar treatment is now considered the standard of care for pancreatic cancer following surgery.
结果：合成了盐酸吉西他滨，总收率15.8%。
目的：合成抗癌药物盐酸吉西他滨并改进合成工艺。
Objective: To synthesize of gemcitabine hydrochloride and optimize the process.
在这些患者中舒尼替尼和卡培他滨的剂量逐步递增。
Sunitinib and capecitabine doses were escalated in serial patient cohorts.
吉西他滨是近年来治疗晚期非小细胞肺癌的有效新药。
Gemcitabine is a new active drug in the treatment of advanced non small cell lung cancer (NSCLC).
吉西他滨30分钟静脉滴注是晚期胰腺癌的标准治疗方案。
Gemcitabine (iv over 30 minutes) is the standard therapy for inoperable pancreatic cancer of advanced stage.
吉西他滨和卡培他滨的组合有时用来治疗转移性肾细胞癌。
A combination of gemcitabine and capecitabine is sometimes used to treat metastatic renal cell cancer.
同时，这些患者既往不能有包含吉西他滨或者顺铂的化疗史。
Patients could not have had prior chemotherapy with gemcitabine or cisplatin.
目的评价紫杉醇联合卡培他滨治疗晚期乳腺癌的疗效和毒副作用。
Objective to evaluate the therapeutic effects and toxicities of paclitaxel and capecitabine combination regimen in the treatment of advanced breast cancer.
目的：提供卡培他滨治疗消化道恶性肿瘤的药物经济学评价依据。
OBJECTIVE:To provide some basis for the evaluation of the pharmacoeconomic value of capecitabine in the treatment of digestive malignant tumor.
厄罗替尼布联合卡培他滨同样用于一线药物吉西他滨治疗失败的患者。
Erlotinib is also being evaluated in combination with capecitabine in patients who failed first-line therapy with gemcitabine.
采用吉西他滨和CD 40抗体治疗后，30%的小鼠肿瘤瘤体缩小。
After treatment with gemcitabine and CD40 antibody, the tumors shrank in 30% of the animals.
目的观察吉西他滨联合伯尔定治疗晚期非小细胞肺癌的疗效及毒副作用。
Objective to observe the efficacy and toxicity of gemcitabine plus Carboplatin in the treatment of advanced non-small-cell lung cancer (NSCLC).
方法：比较卡培他滨与经典MAYO方案在临床疗效和医疗费用方面的特点。
METHODS:The characteristics of therapeutic effect and medical cost were compared between capectabine and classical MAYO program.
目的探讨放射性125I粒子植入联合吉西他滨治疗进展期胰腺癌的临床价值。
To explore the significance of implanted 125i radioactive particles into tumor combined with gemcitabine to treat extended local pancreas cancer.
目的观察吉西他滨联合卡培他滨治疗蒽环类耐药性晚期乳腺癌的疗效与毒性反应。
Objective To observe the results of gemcitabine combined with capecitabine on anthracycline-resistant breast cancer.
结论：吉西他滨联合顺铂的新辅助化疗耐受性好，并且没有破坏胰腺癌的可手术性。
Conclusion: Neoadjuvant chemotherapy with gemcitabine and cisplatin is well tolerated and does not impair resectability of pancreatic cancer.
为此，本研究探讨加速分割放疗同步卡培他滨化疗治疗晚期鼻咽癌的疗效和毒副反应。
In this study, the efficacy and toxicity of accelerated fractionated radiotherapy with concurrent capecitabin chemotherapy for advanced NPC were investigated.
吉西他滨合用贝伐单抗的患者中位生存期为5.7个月，而单用吉西他滨者为6个月。
The median survival for patients taking both Avastin and Gemzar was 5.7 months compared with 6.0 months for patients taking Gemzar alone.
目的观察不同剂量、用法的吉西他滨联合伯尔定治疗晚期非小细胞肺癌的疗效和不良反应。
Objective to observe the efficacy and toxicity of gemcitabine of different dosages and methods plus carboplatin in patients with advanced non-small-cell lung cancer (NSCLC).
对复发性乳腺癌患者，吉西他滨的疗效则明显优于蒽环类和紫杉类药物（P<0。01）。
Results In primary breast cancer, the antitumor effect of taxane is better than anthracycline and gemcitabine(P <0.01).
该研究中，302名患者接受吉西他滨合用贝伐单抗，300名患者接受吉西他滨和安慰剂。
The study researchers assigned 302 patients to receive Avastin and Gemzar and assigned an additional 300 patients to receive Gemzar plus placebo.
这个研究结果表明：服用拉帕替尼和卡培他滨获得更为显著地治疗效果，延迟了肿瘤的生长。
That study revealed that women who took Tykerb in combination with capecitabine were significantly more likely to respond positively to treatment and to experience a delay in tumor growth.
目的观察了解吉西他滨单药治疗老年晚期非小细胞肺癌(NSCLC)的临床疗效和毒性反应。
Objective: to evaluate the clinical effect and toxicity of gemcitabine monotherapy in the treatment of elder advanced non-small cell lung cancer (NSCLC).
目的：探讨卡培他滨联合沙利度胺治疗晚期结直肠癌的近期疗效及癌组织胸苷磷酸化酶的表达。
Objective: To study the efficacy of combined capecitabine with thalidomide in treatment of advanced colorectal cancer and expression of thymidine phosphorylase in colorectal cancer tissue.
卡培他滨是一种新型口服氟尿嘧啶类药物，目前广泛用于乳腺癌、胃肠道肿瘤及头颈部肿瘤的治疗。
Capecitabine is a new oral drug of Fluorouracil (FU), which is widely used in the therapy of breast, gastrointestinal, head and neck cancer.
经过平均2.4年的随访，与常规化疗组相比，卡培他滨治疗组有超过两倍的复发率和两倍的死亡率。
After a median follow-up of 2.4 years, patients on capecitabine were more than twice as likely to have a relapse and twice as likely to die as those receiving standard chemotherapy.
结论：卡培他滨和奥沙利铂用于先前未经治疗的食管癌和胃癌患者，效果分别与氟尿嘧啶和顺铂相同。
Conclusions Capecitabine and oxaliplatin are as effective as fluorouracil and cisplatin, respectively, in patients with previously untreated esophagogastric cancer.
应用推荐